HSBC Holdings
ABVX

HSBC Holdings’s Abivax ABVX Stock Holding History

HSBC Holdings’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Sell
2,284
-13,142
-85% -$1.49M ﹤0.01% 2506
2026
Q1 		$1.71M Buy
15,426
+11,887
+336% +$1.41M ﹤0.01% 1604
2025
Q4 		$462K Buy
+3,539
New +$386K ﹤0.01% 2357

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HSBC Holdings's ABVX Position: Q2 2026 in Review

HSBC Holdings reduced its Abivax (ABVX) stake by 85% in Q2 2026, selling an estimated $1.49M and leaving 2,284 shares worth $308K. The position accounts for ﹤0.01% of the portfolio, ranked #2506.

HSBC Holdings first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.71M in Q1 2026. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • HSBC Holdings held 2,284 shares of Abivax worth $308K as of Q2 2026.
  • HSBC Holdings sold 13,142 Abivax shares in Q2 2026, an estimated $1.49M.
  • Abivax made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2506 holding.
  • HSBC Holdings first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • HSBC Holdings's Abivax position peaked at $1.71M in Q1 2026.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.